IT1231413B - Derivati dell'acido benzimidazolin-2-osso-1-carbossilico utili come antagonisti dei recettori 5-ht - Google Patents

Derivati dell'acido benzimidazolin-2-osso-1-carbossilico utili come antagonisti dei recettori 5-ht

Info

Publication number
IT1231413B
IT1231413B IT8721997A IT2199787A IT1231413B IT 1231413 B IT1231413 B IT 1231413B IT 8721997 A IT8721997 A IT 8721997A IT 2199787 A IT2199787 A IT 2199787A IT 1231413 B IT1231413 B IT 1231413B
Authority
IT
Italy
Prior art keywords
alkyl
hydrogen atom
substituted
mono
optionally
Prior art date
Application number
IT8721997A
Other languages
English (en)
Other versions
IT8721997A0 (it
Inventor
Marco Turconi
Arturo Donetti
Rosamaria Micheletti
Annamaria Uberti
Massimo Nicola
Antonio Giachetti
Ernesto Montagna
Original Assignee
Angeli Inst Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Angeli Inst Spa filed Critical Angeli Inst Spa
Publication of IT8721997A0 publication Critical patent/IT8721997A0/it
Priority to IT8721997A priority Critical patent/IT1231413B/it
Priority to DD88319929A priority patent/DD285354A5/de
Priority to EP88830375A priority patent/EP0309423B1/en
Priority to DE3850203T priority patent/DE3850203T2/de
Priority to ES88830375T priority patent/ES2054872T3/es
Priority to PL1988274751A priority patent/PL151434B1/pl
Priority to IL87795A priority patent/IL87795A/xx
Priority to PL1988279346A priority patent/PL152951B1/pl
Priority to AT88830375T priority patent/ATE107305T1/de
Priority to JP63236179A priority patent/JPH0631225B2/ja
Priority to CA000577840A priority patent/CA1337347C/en
Priority to SI8811778A priority patent/SI8811778A/sl
Priority to NZ226291A priority patent/NZ226291A/xx
Priority to YU177888A priority patent/YU46925B/sh
Priority to AU22378/88A priority patent/AU610040C/en
Priority to HU884970A priority patent/HU200770B/hu
Priority to SU884356601A priority patent/SU1676451A3/ru
Priority to SK6307-88A priority patent/SK278812B6/sk
Priority to NO884202A priority patent/NO169286C/no
Priority to ZA887083A priority patent/ZA887083B/xx
Priority to PH37579A priority patent/PH29923A/en
Priority to DK526188A priority patent/DK172226B1/da
Priority to CS886307A priority patent/CZ279864B6/cs
Priority to UA4356601A priority patent/UA8022A1/uk
Priority to IE286988A priority patent/IE63234B1/en
Priority to FI884350A priority patent/FI89920C/fi
Priority to KR88012299A priority patent/KR960003604B1/ko
Application granted granted Critical
Publication of IT1231413B publication Critical patent/IT1231413B/it
Priority to US07/845,891 priority patent/US5223511A/en
Priority to MX9203249A priority patent/MX9203249A/es
Priority to US08/033,675 priority patent/US5358954A/en
Priority to US08/432,338 priority patent/US5552408A/en
Priority to HRP-1778/88A priority patent/HRP950049B1/xx
Priority to LVP-95-33A priority patent/LV11035B/en
Priority to HU95P/P00691P priority patent/HU211566A9/hu
Priority to HK142195A priority patent/HK142195A/xx
Priority to BR1100514-9A priority patent/BR1100514A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
    • C07D451/06—Oxygen atoms
    • C07D451/12—Oxygen atoms acylated by aromatic or heteroaromatic carboxylic acids, e.g. cocaine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/14—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing 9-azabicyclo [3.3.1] nonane ring systems, e.g. granatane, 2-aza-adamantane; Cyclic acetals thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/06—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing isoquinuclidine ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/08—Bridged systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
IT8721997A 1987-09-23 1987-09-23 Derivati dell'acido benzimidazolin-2-osso-1-carbossilico utili come antagonisti dei recettori 5-ht IT1231413B (it)

Priority Applications (36)

Application Number Priority Date Filing Date Title
IT8721997A IT1231413B (it) 1987-09-23 1987-09-23 Derivati dell'acido benzimidazolin-2-osso-1-carbossilico utili come antagonisti dei recettori 5-ht
DD88319929A DD285354A5 (de) 1987-09-23 1988-09-19 Verfahren zur herstellung von 2-oxo-benzimidazolin-1-carbonsaeurederivate
EP88830375A EP0309423B1 (en) 1987-09-23 1988-09-19 New benzimidazoline-2-oxo-1-carboxylic acid derivatives useful as 5-ht receptor antagonists
DE3850203T DE3850203T2 (de) 1987-09-23 1988-09-19 Benzimidazolin-2-oxo-1-carboxylsäure-Derivate, verwendbar als Antagonisten von 5-HT-Rezeptoren.
ES88830375T ES2054872T3 (es) 1987-09-23 1988-09-19 Nuevos derivados de acido bencimidazolin-2-oxo-1-carboxilico utiles como antagonistas de los receptores 5-ht.
PL1988274751A PL151434B1 (en) 1987-09-23 1988-09-19 New benzimidazoline-2-oxo-1-carboxylic acid derivatives useful as 5-ht receptor antagonists.
IL87795A IL87795A (en) 1987-09-23 1988-09-19 Benzimidazolin-2-oxo- 1-carboxylic acid ester and amide derivatives, their preparation and pharmaceutical compositions containing them
PL1988279346A PL152951B1 (en) 1987-09-23 1988-09-19 Method for manufacturing new derivatives of benzimidazoline-2-oxo-1-carboxylic acid
AT88830375T ATE107305T1 (de) 1987-09-23 1988-09-19 Benzimidazolin-2-oxo-1-carboxylsäure-derivate, verwendbar als antagonisten von 5-ht-rezeptoren.
JP63236179A JPH0631225B2 (ja) 1987-09-23 1988-09-20 ５−ｈｔ受容体拮抗剤として有用な新規ベンズイミダゾリン−２−オキソ−１−カルボン酸誘導体
CA000577840A CA1337347C (en) 1987-09-23 1988-09-20 Benzimidazoline-2-one-1-carboxylic acid derivatives useful as 5-ht receptor antagonists
SI8811778A SI8811778A (sl) 1987-09-23 1988-09-21 Postopek za pripravo novih derivatov benzimidazolin-2-okso-1-karboksilne kisline
NZ226291A NZ226291A (en) 1987-09-23 1988-09-21 Heterocyclyl-substituted benzimidazoline-2-oxo 1-carboxylic acid derivatives and pharmaceutical compositions
YU177888A YU46925B (sh) 1987-09-23 1988-09-21 Postupak za dobijanje novih derivata benzimidazolin-2-okso-1-karboksilne kiseline
AU22378/88A AU610040C (en) 1987-09-23 1988-09-21 Benzimidazoline-2-oxo-1-carboxylic acid derivatives
NO884202A NO169286C (no) 1987-09-23 1988-09-22 Analogifremgangsmaate for fremstilling av terapeutisk aktive benzimidazolin-2-okso-1-karboksylsyrederivater
SU884356601A SU1676451A3 (ru) 1987-09-23 1988-09-22 Способ получени производных бензимидазола в виде смеси изомеров или индивидуальных изомеров в свободном виде или в виде их физиологически приемлемых солей
SK6307-88A SK278812B6 (sk) 1987-09-23 1988-09-22 Derivát kyseliny 2,3-dihydro-2-oxo-1h-benzimidazol
HU884970A HU200770B (en) 1987-09-23 1988-09-22 Process for producing new benzimidazoline-2-oxo-1-carboxylic acid derivatives with 5-ht receptor antagonist action, as well as pharmaceutical compositions comprising same
ZA887083A ZA887083B (en) 1987-09-23 1988-09-22 New benzimidazoline-2-one-1-carboxylic and derivatives useful as 5-ht receptor antagonists
PH37579A PH29923A (en) 1987-09-23 1988-09-22 New benzimidazoline-2-oxo-1-carboxylic acid derivatives useful as 5-nt receptor antagonists
DK526188A DK172226B1 (da) 1987-09-23 1988-09-22 Benzimidazolin-2-oxo-1-carboxylsyrederivater, mellemprodukt herfor, farmaceutiske præparater indeholdende forbindelserne og anvendelse af forbindelserne til fremstilling af farmaceutiske præparater
CS886307A CZ279864B6 (cs) 1987-09-23 1988-09-22 Derivát kyseliny benzimidazolin-2-oxo-1-karboxylové, způsob jeho výroby a farmaceutický prostředek s jeho obsahem
UA4356601A UA8022A1 (uk) 1987-09-23 1988-09-22 Спосіб одержання похідних бензімідазолу у вигляді суміші ізомерів або індивідуальних ізомерів у вільному вигляді або у вигляді їх фізіологічно прийнятих солей
IE286988A IE63234B1 (en) 1987-09-23 1988-09-22 New benzimidazoline-2-oxo-1-carboxylic acid derivatives useful as 5-ht receptor antagonists
FI884350A FI89920C (fi) 1987-09-23 1988-09-22 Foerfarande foer framstaellning av farmakologiskt verksamma bensimidazolin-2-oxo-1-karboxylsyraderivat
KR88012299A KR960003604B1 (en) 1987-09-23 1988-09-23 Benzimidazoline-2-oxo-1-carboxylic acid derivatives
US07/845,891 US5223511A (en) 1987-09-23 1992-03-04 Benzimidazoline-2-oxo-1-carboxylic acid compounds useful as 5-HT receptor antagonists
MX9203249A MX9203249A (es) 1987-09-23 1992-06-24 Derivados del acido bencimidazolin-2-oxo-1-carboxilico y composiciones farmaceuticas que los contienen.
US08/033,675 US5358954A (en) 1987-09-23 1993-03-16 Benzimidazoline-2-oxo-1-carboxylic acid derivatives useful as 5-HT receptor antagonists
US08/432,338 US5552408A (en) 1987-09-23 1994-05-01 Benzimidazoline-2-oxo-1-carboxylic acid derivatives useful as 5-ht receptor antagonists
HRP-1778/88A HRP950049B1 (en) 1987-09-23 1995-02-03 Process for the preparation of new benzimidazoline-2oxo-1-carboxylic acid derivatives
LVP-95-33A LV11035B (en) 1987-09-23 1995-02-17 New benzimidazoline-2-oxo-1-carboxylic acid derivatives useful as 5-ht receptor antagonists
HU95P/P00691P HU211566A9 (en) 1987-09-23 1995-06-30 New benzimidazoline-2-oxo-1-carboxylic acid derivatives useful as 5-ht receptor antagonists
HK142195A HK142195A (en) 1987-09-23 1995-09-07 New benzimidazoline-2-oxo-1-carboxylic acid derivatives useful as 5-ht receptor antagonists
BR1100514-9A BR1100514A (pt) 1987-09-23 1997-05-13 Processo para a preparação de compostos derivados do ácido benzimidazolino - 2 - oxo - 1 - carboxìlico; produto / composto / composição

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT8721997A IT1231413B (it) 1987-09-23 1987-09-23 Derivati dell'acido benzimidazolin-2-osso-1-carbossilico utili come antagonisti dei recettori 5-ht

Publications (2)

Publication Number Publication Date
IT8721997A0 IT8721997A0 (it) 1987-09-23
IT1231413B true IT1231413B (it) 1991-12-04

Family

ID=11189966

Family Applications (1)

Application Number Title Priority Date Filing Date
IT8721997A IT1231413B (it) 1987-09-23 1987-09-23 Derivati dell'acido benzimidazolin-2-osso-1-carbossilico utili come antagonisti dei recettori 5-ht

Country Status (28)

Country Link
EP (1) EP0309423B1 (it)
JP (1) JPH0631225B2 (it)
KR (1) KR960003604B1 (it)
AT (1) ATE107305T1 (it)
BR (1) BR1100514A (it)
CA (1) CA1337347C (it)
CZ (1) CZ279864B6 (it)
DD (1) DD285354A5 (it)
DE (1) DE3850203T2 (it)
DK (1) DK172226B1 (it)
ES (1) ES2054872T3 (it)
FI (1) FI89920C (it)
HK (1) HK142195A (it)
HU (2) HU200770B (it)
IE (1) IE63234B1 (it)
IL (1) IL87795A (it)
IT (1) IT1231413B (it)
LV (1) LV11035B (it)
MX (1) MX9203249A (it)
NO (1) NO169286C (it)
NZ (1) NZ226291A (it)
PH (1) PH29923A (it)
PL (2) PL151434B1 (it)
SK (1) SK278812B6 (it)
SU (1) SU1676451A3 (it)
UA (1) UA8022A1 (it)
YU (1) YU46925B (it)
ZA (1) ZA887083B (it)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1230881B (it) * 1989-06-20 1991-11-08 Angeli Inst Spa Derivati del r(-) 3-chinuclidinolo
CA2030051C (en) * 1989-11-17 2001-08-07 Haruhiko Kikuchi Indole derivatives
EP0436245A1 (en) * 1989-12-27 1991-07-10 Duphar International Research B.V Substituted 3,4-annelated benzimidazol-2(1H)-ones
JP3122671B2 (ja) * 1990-05-23 2001-01-09 協和醗酵工業株式会社 複素環式化合物
US5192770A (en) * 1990-12-07 1993-03-09 Syntex (U.S.A.) Inc. Serotonergic alpha-oxoacetamides
JP3026845B2 (ja) * 1991-02-20 2000-03-27 日清製粉株式会社 ピペリジン誘導体
IT1250629B (it) * 1991-07-04 1995-04-21 Boehringer Ingelheim Italia Uso dei derivati dell'acido benzimidazolin-2-oxo-1-carbossilico.
GB9204565D0 (en) * 1992-03-03 1992-04-15 Smithkline Beecham Plc Pharmaceuticals
JPH05310732A (ja) * 1992-03-12 1993-11-22 Mitsubishi Kasei Corp シンノリン−３−カルボン酸誘導体
JP2699794B2 (ja) * 1992-03-12 1998-01-19 三菱化学株式会社 チエノ〔３，２−ｂ〕ピリジン誘導体
WO1993024117A2 (en) * 1992-05-23 1993-12-09 Smithkline Beecham Plc Medicaments for the treatment of anxiety
US5521193A (en) * 1992-06-24 1996-05-28 G. D. Searle & Co. Benzimidazole compounds
US5280028A (en) * 1992-06-24 1994-01-18 G. D. Searle & Co. Benzimidazole compounds
US5300512A (en) * 1992-06-24 1994-04-05 G. D. Searle & Co. Benzimidazole compounds
WO1994000113A2 (en) * 1992-06-27 1994-01-06 Smithkline Beecham Plc Medicaments containing 5-ht4 receptor antagonists
FR2694292B1 (fr) * 1992-07-29 1994-10-21 Esteve Labor Dr Dérivés de benzimidazole-2-thione-, leur préparation et leur application en tant que médicament.
US5534521A (en) * 1993-06-23 1996-07-09 G. D. Searle & Co. Benzimidazole compounds
GB9502582D0 (en) * 1995-02-10 1995-03-29 Smithkline Beecham Plc Novel process
AU755117B2 (en) * 1999-05-12 2002-12-05 Sydney Gordon Low A message processing system
TW200533348A (en) 2004-02-18 2005-10-16 Theravance Inc Indazole-carboxamide compounds as 5-ht4 receptor agonists
TWI351282B (en) 2004-04-07 2011-11-01 Theravance Inc Quinolinone-carboxamide compounds as 5-ht4 recepto
US7728006B2 (en) 2004-04-07 2010-06-01 Theravance, Inc. Quinolinone-carboxamide compounds as 5-HT4 receptor agonists
US8309575B2 (en) 2004-04-07 2012-11-13 Theravance, Inc. Quinolinone-carboxamide compounds as 5-HT4 receptor agonists
JP4129445B2 (ja) * 2004-06-15 2008-08-06 ファイザー・インク ベンズイミダゾロンカルボン酸誘導体
WO2006052640A1 (en) 2004-11-05 2006-05-18 Theravance, Inc. 5-ht4 receptor agonist compounds
US7396933B2 (en) 2004-11-05 2008-07-08 Theravance, Inc. Quinolinone-carboxamide compounds
RU2404179C2 (ru) 2004-12-22 2010-11-20 Тереванс, Инк. Индазол-карбоксамидные соединения
US7446114B2 (en) 2005-03-02 2008-11-04 Theravance, Inc. Quinolinone compounds as 5-HT4 receptor agonists
WO2006133104A2 (en) 2005-06-07 2006-12-14 Theravance, Inc. Benzoimidazolone-carboxamide compounds as 5-ht4 receptor agonists
MY143574A (en) 2005-11-22 2011-05-31 Theravance Inc Carbamate compounds as 5-ht4 receptor agonists
NZ583487A (en) * 2007-07-27 2011-09-30 Actelion Pharmaceuticals Ltd 2-aza-bicyclo[3.3.0]octane derivatives
EP2253316B1 (en) 2009-05-20 2013-08-14 INSERM (Institut National de la Santé et de la Recherche Médicale) Serotonin 5-HT3 receptor antagonists for use in the treatment or prevention of an inner ear pathology with vestibular deficits
PT2432467T (pt) 2009-05-20 2018-04-04 Inst Nat Sante Rech Med Antagonistas recetores de serotina 5-ht3 para utilização no tratamento de distúrbios vestibulares lesionais
EP2701699B1 (en) 2011-04-28 2019-10-16 The Broad Institute, Inc. Inhibitors of histone deacetylase
WO2014018979A1 (en) 2012-07-27 2014-01-30 The Broad Institute, Inc. Inhibitors of histone deacetylase
WO2014100438A1 (en) 2012-12-20 2014-06-26 The Broad Institute, Inc. Cycloalkenyl hydroxamic acid derivatives and their use as histone deacetylase inhibitors
AR101131A1 (es) 2014-07-11 2016-11-23 Comentis Inc QUINUCLIDINAS PARA LA MODULACIÓN DE ACTIVIDAD DE a7
CA3125731A1 (en) 2018-01-12 2019-07-18 KDAc Therapeutics, Inc. Combination of a selective histone deacetylase 3 (hdac3) inhibitor and an immunotherapy agent for the treatment of cancer

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4250176A (en) * 1976-12-21 1981-02-10 Janssen Pharmaceutica N.V. Piperazine derivatives
EP0093488A3 (en) * 1982-03-18 1984-05-23 Beecham Group Plc Nortropyl benzopyrrolinone compounds, process for their preparation and pharmaceutical compositions containing them
ES2053451T3 (es) * 1986-01-07 1994-08-01 Beecham Group Plc Un procedimiento para la preparacion de un compuesto que tiene propiedades farmacologicas utiles.

Also Published As

Publication number Publication date
SK630788A3 (en) 1998-03-04
AU610040B2 (en) 1991-05-09
PL151434B1 (en) 1990-09-28
DK526188A (da) 1989-03-24
CZ630788A3 (en) 1995-04-12
CA1337347C (en) 1995-10-17
UA8022A1 (uk) 1995-12-26
ES2054872T3 (es) 1994-08-16
JPH01106882A (ja) 1989-04-24
BR1100514A (pt) 2002-04-02
EP0309423A3 (en) 1989-11-29
ZA887083B (en) 1990-05-30
HUT48250A (en) 1989-05-29
AU2237888A (en) 1989-03-23
KR960003604B1 (en) 1996-03-20
IE882869L (en) 1989-03-23
IL87795A (en) 1993-02-21
DK526188D0 (da) 1988-09-22
HU211566A9 (en) 1995-12-28
DE3850203D1 (de) 1994-07-21
DK172226B1 (da) 1998-01-12
HU200770B (en) 1990-08-28
FI89920B (fi) 1993-08-31
SK278812B6 (sk) 1998-03-04
NO169286B (no) 1992-02-24
KR890005105A (ko) 1989-05-11
IT8721997A0 (it) 1987-09-23
EP0309423A2 (en) 1989-03-29
IL87795A0 (en) 1989-03-31
PL152951B1 (en) 1991-02-28
JPH0631225B2 (ja) 1994-04-27
NO884202D0 (no) 1988-09-22
IE63234B1 (en) 1995-04-05
ATE107305T1 (de) 1994-07-15
NZ226291A (en) 1991-05-28
LV11035A (lv) 1996-02-20
PL279346A1 (en) 1990-01-08
SU1676451A3 (ru) 1991-09-07
FI89920C (fi) 1993-12-10
NO169286C (no) 1992-06-03
MX9203249A (es) 1992-07-01
YU177888A (en) 1990-06-30
CZ279864B6 (cs) 1995-07-12
DD285354A5 (de) 1990-12-12
FI884350A (fi) 1989-03-24
HK142195A (en) 1995-09-15
PL274751A1 (en) 1989-09-04
NO884202L (no) 1989-03-28
DE3850203T2 (de) 1994-09-22
LV11035B (en) 1996-08-20
YU46925B (sh) 1994-06-24
PH29923A (en) 1996-09-16
EP0309423B1 (en) 1994-06-15
FI884350A0 (fi) 1988-09-22

Similar Documents

Publication Publication Date Title
IT1231413B (it) Derivati dell&#39;acido benzimidazolin-2-osso-1-carbossilico utili come antagonisti dei recettori 5-ht
DK0526434T3 (da) Benzimidazolonderivater som 5-HT1A- og 5-HT2-antagonister
HUP0401855A2 (hu) Pirimidin-származékok mint az inzulinszerű növekedési faktor-1 receptor (IGF-1R) modulátorai, eljárás előállításukra, alkalmazásuk és a vegyületeket tartalmazó gyógyszerkészítmények
PT93066A (pt) Processo para a preparacao de derivados heterociclicos contendo nucleos bengenicos fundidos com nucleos monoazotados substituidos e de composicoes farmaceuticas que os contem
ES8403899A1 (es) Un procedimiento para la preparacion de nuevos derivados de benzamida.

Legal Events

Date Code Title Description
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19930929